NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Celsion Corporation (NASDAQ: CLSN)
CLSN Technical Analysis
2.5
As on 22nd Nov 2022 CLSN SHARE Price closed @ 1.45 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.57 & Strong Buy for SHORT-TERM with Stoploss of 1.16 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CLSNSHARE Price
Open | 1.42 | Change | Price | % |
High | 1.46 | 1 Day | 0.02 | 1.40 |
Low | 1.40 | 1 Week | -0.08 | -5.23 |
Close | 1.45 | 1 Month | -0.15 | -9.38 |
Volume | 29458 | 1 Year | 0.24 | 19.83 |
52 Week High 6.22 | 52 Week Low 0.32 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
CLSN Daily Charts |
CLSN Intraday Charts |
Whats New @ Bazaartrend |
CLSN Free Analysis |
|
CLSN Important Levels Intraday
RESISTANCE | 1.57 |
RESISTANCE | 1.53 |
RESISTANCE | 1.51 |
RESISTANCE | 1.48 |
SUPPORT | 1.42 |
SUPPORT | 1.39 |
SUPPORT | 1.37 |
SUPPORT | 1.33 |
CLSN Forecast March 2024
4th UP Forecast | 2.12 |
3rd UP Forecast | 1.91 |
2nd UP Forecast | 1.77 |
1st UP Forecast | 1.64 |
1st DOWN Forecast | 1.26 |
2nd DOWN Forecast | 1.13 |
3rd DOWN Forecast | 0.99 |
4th DOWN Forecast | 0.78 |
CLSN Weekly Forecast
4th UP Forecast | 2.07 |
3rd UP Forecast | 1.87 |
2nd UP Forecast | 1.75 |
1st UP Forecast | 1.62 |
1st DOWN Forecast | 1.28 |
2nd DOWN Forecast | 1.15 |
3rd DOWN Forecast | 1.03 |
4th DOWN Forecast | 0.83 |
CLSN Forecast2024
4th UP Forecast | 15.65 |
3rd UP Forecast | 11.1 |
2nd UP Forecast | 8.28 |
1st UP Forecast | 5.47 |
1st DOWN Forecast | -2.57 |
2nd DOWN Forecast | -5.38 |
3rd DOWN Forecast | -8.2 |
4th DOWN Forecast | -12.75 |
Celsion Corporation ( NASDAQ USA Symbol : CLSN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CLSN Other Details
Segment | EQ | |
Market Capital | 78438584.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
CLSN Address
CLSN Latest News
CLSN Business Profile
Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of directed chemotherapies, DNA-mediated immunotherapy, and vaccines. Its lead product candidate is ThermoDox, a liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for the treatment of primary liver cancer. The company is also developing GEN-1, a DNA-based immunotherapeutic product, which is in Phase II clinical trials for the localized treatment of ovarian cancers. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey. Address: 997 Lenox Drive, Lawrenceville, NJ, United States, 08648
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service